Genetic Testing Low in Castration-Resistant Prostate Cancer
TOPLINE: A minority of patients with metastatic castration-resistant prostate cancer (mCRPC) in the United States undergo genetic testing for homologous recombination repair (HRR) mutations, despite the potential prognostic and predictive value of these …